ARCHIVES

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

House Passes Cancer Bill With Mandates for NCI

September 28, 2012

In Brief: Columbia-Presbyterian Cancer center to Be Renamed After Donor Herbert Irving

December 6, 1996

In Brief: Travel Grants available For 14th International Congress; NIH Seeks Nurses For Study Sections

November 22, 1985

In Brief: Five Candidates Interview for NCI Job, Harris To Make Recommendation Within Month

May 2, 1980

Two Groups Take Different Approaches To Managing Toxicity Of Saltz Regimen.

June 22, 2001